Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Publication date:
2010
Publisher version:
Citación:
International Journal of Neuropsychopharmacology, 13(3), p. 305-320 (2010); doi:10.1017/S1461145709990423
Descripción física:
p. 305-320
ISSN:
Identificador local:
20100334
Patrocinado por:
This study (Silver: D1448C00011) was supported by AstraZeneca Pharmaceuticals.
Files in this item
